BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25362357)

  • 1. Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues.
    Sun R; Wang X; Zhu H; Mei H; Wang W; Zhang S; Huang J
    Oncotarget; 2014 Dec; 5(23):12398-409. PubMed ID: 25362357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAMP3 and TP53 overexpression predicts poor outcome in laryngeal squamous cell carcinoma.
    Qiu X; You Y; Huang J; Wang X; Zhu H; Wang Z
    Int J Clin Exp Pathol; 2015; 8(5):5519-27. PubMed ID: 26191259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Expression of LAMP3 Is a Novel Biomarker of Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
    Liao X; Chen Y; Liu D; Li F; Li X; Jia W
    Int J Mol Sci; 2015 Jul; 16(8):17655-67. PubMed ID: 26263981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival.
    Wang Q; Ni Q; Wang X; Zhu H; Wang Z; Huang J
    Med Oncol; 2015 Jan; 32(1):372. PubMed ID: 25428385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer.
    Kanao H; Enomoto T; Kimura T; Fujita M; Nakashima R; Ueda Y; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Tanigami A; Yoshino K; Murata Y
    Cancer Res; 2005 Oct; 65(19):8640-5. PubMed ID: 16204031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer.
    Nagelkerke A; Mujcic H; Bussink J; Wouters BG; van Laarhoven HW; Sweep FC; Span PN
    Cancer; 2011 Aug; 117(16):3670-81. PubMed ID: 21319150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAMP3 expression correlated with poor clinical outcome in human ovarian cancer.
    Wang D; Cao X; Zhang Y; Liu Y; Yao C; Ge W; Xu Y
    Tumour Biol; 2017 Mar; 39(3):1010428317695014. PubMed ID: 28349821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy.
    Nagelkerke A; Sieuwerts AM; Bussink J; Sweep FC; Look MP; Foekens JA; Martens JW; Span PN
    Endocr Relat Cancer; 2014 Feb; 21(1):101-12. PubMed ID: 24434718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3.
    Mujcic H; Rzymski T; Rouschop KM; Koritzinsky M; Milani M; Harris AL; Wouters BG
    Radiother Oncol; 2009 Sep; 92(3):450-9. PubMed ID: 19726095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance and Prognostic Value of the Expression of LAMP3 in Oral Squamous Cell Carcinoma.
    Lu J; Ma H; Lian S; Huang D; Lian M; Zhang Y; Huang J; Feng X
    Dis Markers; 2017; 2017():1218254. PubMed ID: 28607528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response.
    Nagelkerke A; Bussink J; Mujcic H; Wouters BG; Lehmann S; Sweep FC; Span PN
    Breast Cancer Res; 2013 Jan; 15(1):R2. PubMed ID: 23294542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAMP3 plays an oncogenic role in osteosarcoma cells partially by inhibiting TP53.
    Liu S; Yue J; Du W; Han J; Zhang W
    Cell Mol Biol Lett; 2018; 23():33. PubMed ID: 30008754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLL2 protein is a prognostic marker for gastrointestinal diffuse large B-cell lymphoma.
    Ye H; Lu L; Ge B; Gao S; Ma Y; Liang B; Yu K; Yang K
    Int J Clin Exp Pathol; 2015; 8(10):13043-50. PubMed ID: 26722499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
    Pak MG; Koh HJ; Roh MS
    Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.
    Bi J; Lau SH; Lv ZL; Xie D; Li W; Lai YR; Zhong JM; Wu HQ; Su Q; He YL; Zhan WH; Wen JM; Guan XY
    Hum Pathol; 2009 Dec; 40(12):1790-7. PubMed ID: 19765801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
    Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
    Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
    Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma.
    Xia B; Zhang L; Guo SQ; Li XW; Qu FL; Zhao HF; Zhang LY; Sun BC; You J; Zhang YZ
    World J Gastroenterol; 2015 Feb; 21(8):2433-42. PubMed ID: 25741152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.